Guided Therapeutics EV/EBITDA
What is the EV/EBITDA of Guided Therapeutics?
The EV/EBITDA of Guided Therapeutics, Inc. is N/A
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Health Care sector on OTC compared to Guided Therapeutics
What does Guided Therapeutics do?
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Companies with ev/ebitda similar to Guided Therapeutics
- Exro Technologies Inc has EV/EBITDA of N/A
- Pacific Imperial Mines has EV/EBITDA of N/A
- Kalina Power has EV/EBITDA of N/A
- TransAtlantic Petroleum Ltd has EV/EBITDA of N/A
- CBD Global Sciences has EV/EBITDA of N/A
- Paradigm Biopharmaceuticals has EV/EBITDA of N/A
- Guided Therapeutics has EV/EBITDA of N/A
- KRM22 Plc has EV/EBITDA of N/A
- CMC Metals has EV/EBITDA of N/A
- Lamaska Capital has EV/EBITDA of N/A
- Riverside Resources has EV/EBITDA of N/A
- Canarc Resource has EV/EBITDA of N/A
- RTG Mining has EV/EBITDA of N/A